Trial Profile
Clinical Trials Insight: 700026919
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2007
Price :
$35
*
At a glance
- Drugs Teverelix (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Ardana plc
- 13 Sep 2007 New trial record.